In acute myelogenous leukemia (AML), METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells by promoting m6A-mediated translation of apoptotic genes such as C-MYC, BCL-2, and PTEN (73). The gene discussed is MYC; the disease is acute myeloid leukemia.